Navigation Links
Marrow Donation From Teenage Stranger Saves Man's Life
Date:2/11/2011

what doctors call a 10 out of 10 match, which is about the best you can hope for," Munroe said.

The young woman had signed up for the registry at a Warped tour concert, inspired by one of her favorite musicians who had gotten a marrow donation from his sister, Munroe later learned.

She took medication to boost her marrow's production of stem cells, and five days later had blood drawn and the excess stem cells filtered off. After she had the blood drawn, she had a tattoo done at the needle's entry point to signify the piece of herself she'd given away, Munroe said.

In the meantime, doctors had gotten Munroe's leukemia into remission through chemotherapy. They then destroyed his immune system with chemotherapy to prepare him for the transplant. Munroe had to be kept in isolation for a month during the process, to protect him from infection.

"On the tenth day, they brought her blood into my hospital room and began to drip it into my IV," he said. "They sit there really patiently for the first hour. The first hour is a good sign of whether the body will accept or reject what's being put into it. Their hope is the new healthy white blood cells will eat up the old nasty system you had."

The transplant took, although Munroe said that his body is still recuperating from the experience.

A year after the transplant, Munroe learned the identity of his donor. He reached out to her through Facebook to thank her. They've been corresponding ever since, and he said he hopes to meet her soon.

"I sent her an e-mail and said, 'Look, you saved my life,'" Munroe said. "'You saved my wife from being a widow. You saved my children from being fatherless. You are a hero of ours.'"

More information

A companion article on donating blood and organs offers more on what's involved.

SOURCE: Jim Munroe, Colleyville, Texas
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Study identifies drug resistance of CLL in bone marrow and lymph nodes
2. Jefferson study determines bone marrow stromal stem cells may aid in stroke recovery
3. OHSU research suggests compound administered during some bone marrow transplants elevates risks
4. Experimental Drug Shows Promise for Bone Marrow Disorder
5. Selected cells from blood or bone marrow may provide a route to healing blood vessels
6. Effective inducing systems of hepatic differentiation from bone marrow mesenchymal stem cells
7. Mount Sinai discovers bone marrow plays critical role in enhancing immune response to viruses
8. African-Americans and women are less likely to undergo bone marrow transplantation
9. Scripps Blood & Marrow Transplant Program Celebrates 30th Anniversary of Providing Life-Saving Care
10. Bone Marrow Cancer Patients May Benefit From Drug Combo
11. Vertebroplasty: Integral to treating back pain in blood marrow cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... Experimental Biology and Medicine a multidisciplinary ... Paul Kenis in the Institute of Genomic Biology ... Illinois Urbana-Champaign describe their recent work on subcellular ... of cell functions including energy metabolism, signaling, and ... regulating normal cellular behavior, redox status has been ...
(Date:4/17/2014)... Colo. (April 17, 2014) Two recent papers ... researcher and colleagues may help scientists develop treatments ... Yellow fever, Japanese encephalitis and other disease-causing flaviviruses. ... biochemistry and molecular genetics at the School of ... Howard Hughes Medical Institute, and colleagues recently published ...
(Date:4/17/2014)... Pediatrician-in-Chief Jon McCullers, MD, was recently invited to ... Nature Reviews Microbiology , one of the ... world-renowned infectious disease specialist, and chair of the ... Health Science Center, analyzed the epidemiology and microbiology ... pandemics, as well as more recent 2009 novel ...
(Date:4/17/2014)... NY, April 17, 2014U.S. military personnel who served ... impact" concussive traumatic brain injury (TBI) were compared ... for other medical reasons. Differences in measures of ... 6-12 months after injury are reported in an ... peer-reviewed journal from Mary Ann Liebert, Inc., publishers. ...
(Date:4/17/2014)... million older Americans suffer from depression, often brought on ... research a project that followed the lives of ... found that Internet use among the elderly can reduce ... , "That,s a very strong effect," said Shelia Cotten, ... and media who led the project. "And it all ...
Breaking Medicine News(10 mins):Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Internet use can help ward off depression among elderly 2
... A short-term, very-high dose regimen of the immune-suppressing drug ... in most of a small group of patients studied ... disease, Johns Hopkins researchers report. The findings in nine ... suggest new ways to treat a disease that tends ...
... Bulge with Hoodia and Bitter Orange, LOS ... fatty,and unhealthy coffee creamers, Java Solutions today announces ... creamer to start your day off,with a weight-loss ... of,French vanilla and non-fat buttercream with Hoodia, a ...
... to Solantic Board, JACKSONVILLE, Fla., June 10 ... urgent care, today announced,the appointment of Tom Scully ... a General Partner with New York City Private ... largest private equity investor in,healthcare. In addition, Mr. ...
... 10 Christine Carson Filipovich, a,graduate of Venture ... Nursing Resources, Inc., was honored last month with ... Bolton School of Nursing at,Case Western Reserve University ... an alumna or alumnus "who has demonstrated,outstanding leadership ...
... no longer just for doctors as PointOne ... WAUWATOSA, Wis., June 10 PointOne Systems, ... tool, known as,RedBox Technology, will begin providing reports ... dramatic change from the industry,s focus,on hospitals, research ...
... Information technology has the power,"to transform data ... Co. executive Carly Fiorina once explained., ... Ingenious Med,s IM Quality,Measures(TM), a software package ... capture, report, and submit quality performance,metrics. Physicians ...
Cached Medicine News:Health News:'HiCy' drug regimen reverses ms symptoms in selected patients 2Health News:'HiCy' drug regimen reverses ms symptoms in selected patients 3Health News:Leaner Coffee Creamer Boosts Metabolism and Curbs Appetite 2Health News:Healthcare Veteran Joins Solantic Board of Directors 2Health News:Nursing Entrepreneur Whose Business Career Was Spurred by Venture Training is Honored with Alumna Award from Case Western Reserve University 2Health News:PointOne Launches New Business Direction, Healthcare Analytics Beyond Hospitals 2Health News:Ingenious Med's IM Quality Measures(TM) Delivers Insight About Hospitalist Performance 2Health News:Ingenious Med's IM Quality Measures(TM) Delivers Insight About Hospitalist Performance 3Health News:Ingenious Med's IM Quality Measures(TM) Delivers Insight About Hospitalist Performance 4
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Advanced Drug Delivery Systems -- Focus on ... STUDY OBJECTIVES A ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... 1, 2007 - Introgen Therapeutics, Inc.,(NASDAQ:INGN) reported promising ... novel investigational mda-7/IL-24 tumor,suppressor agent, in patients with ... were presented today at the,annual meeting of the ... 22-patient trial, INGN 241 induced killing in all ...
... Inc.,(TSX: TLN) announced today that preliminary data from ... cancer,patients was published in abstract form as part ... Meeting in Chicago,Illinois. In the Phase I dose ... two ovarian, one duodenal and one,glioma), that had ...
Cached Medicine Technology:Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241,in Patients With Advanced Solid Tumors 2Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241,in Patients With Advanced Solid Tumors 3Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 2Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 3
... Bringing together the best of both ... intraocular instrument is the latest addition ... lightweight Eraser bipolar cautery instruments for ... hemostasis with extrusion aspiration and backflush ...
...
...
...
Medicine Products: